141 related articles for article (PubMed ID: 8033379)
1. Screening for glucose-6-phosphate dehydrogenase deficiency prior to dapsone therapy.
Todd P; Samaratunga IR; Pembroke A
Clin Exp Dermatol; 1994 May; 19(3):217-8. PubMed ID: 8033379
[TBL] [Abstract][Full Text] [Related]
2. Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone.
Pamba A; Richardson ND; Carter N; Duparc S; Premji Z; Tiono AB; Luzzatto L
Blood; 2012 Nov; 120(20):4123-33. PubMed ID: 22993389
[TBL] [Abstract][Full Text] [Related]
3. Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria.
Hu Y; Geere M; Awan M; Leavitt AD; Brown LE; Pearson HJ; Gandelman JS; Kogan SC
Hematology; 2022 Dec; 27(1):1253-1258. PubMed ID: 36444994
[TBL] [Abstract][Full Text] [Related]
4. Dapsone-Associated Hemolytic Anemia in Renal Transplant Recipients With Normal Glucose-6-Phosphate-Dehydrogenase Levels.
Khatri A; Lal M R S; Bhaskaran MC
Am J Ther; 2022 May-Jun 01; 29(3):e369-e372. PubMed ID: 32947344
[No Abstract] [Full Text] [Related]
5. Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review.
Youngster I; Arcavi L; Schechmaster R; Akayzen Y; Popliski H; Shimonov J; Beig S; Berkovitch M
Drug Saf; 2010 Sep; 33(9):713-26. PubMed ID: 20701405
[TBL] [Abstract][Full Text] [Related]
6. Glucose-6-phosphate dehydrogenase deficiency and intravascular haemolysis.
Onadeko BO; Bademosi O
Ir J Med Sci; 1974 Jul; 143(4):208-13. PubMed ID: 4852166
[No Abstract] [Full Text] [Related]
7. [Congenital hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency].
Mura M; Saidi R; Wolf A; Moalic JL; Oliver M
Med Trop (Mars); 2009 Dec; 69(6):551-5. PubMed ID: 20099666
[TBL] [Abstract][Full Text] [Related]
8. Is dapsone safe?
Pettit JH
Int J Dermatol; 1981 Mar; 20(2):106-7. PubMed ID: 7216589
[No Abstract] [Full Text] [Related]
9. Dapsone-induced haemolytic anaemia and agranulocytosis in a patient with normal glucose-6-phosphate-dehydrogenase activity.
Figueiredo MS; Pinto BO; Zago MA
Acta Haematol; 1989; 82(3):144-5. PubMed ID: 2510435
[TBL] [Abstract][Full Text] [Related]
10. The antimalarial and hemolytic properties of 4,4-diaminodiphenyl sulfone (DDS).
Powell RD; DeGowin RL; Eppes RB; McNamara JV; Carson PE
Int J Lepr Other Mycobact Dis; 1967; 35(4):590-604. PubMed ID: 4869693
[No Abstract] [Full Text] [Related]
11. G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications.
Luzzatto L; Seneca E
Br J Haematol; 2014 Feb; 164(4):469-80. PubMed ID: 24372186
[TBL] [Abstract][Full Text] [Related]
12. Glibenclamide-induced acute haemolytic anaemia revealing a G6PD-deficiency.
Vinzio S; Andrès E; Perrin AE; Schlienger JL; Goichot B
Diabetes Res Clin Pract; 2004 Jun; 64(3):181-3. PubMed ID: 15126005
[TBL] [Abstract][Full Text] [Related]
13. G6PD gene mutations in India producing drug-induced haemolytic anaemia.
Sukumar S; Colah R; Mohanty D
Br J Haematol; 2002 Mar; 116(3):671-2. PubMed ID: 11849231
[TBL] [Abstract][Full Text] [Related]
14. Inherited, non-spherocytic haemolysis due to deficiency of glucose-6-phosphate dehydrogenase.
Ronquist G; Theodorsson E
Scand J Clin Lab Invest; 2007; 67(1):105-11. PubMed ID: 17365988
[TBL] [Abstract][Full Text] [Related]
15. Haemolytic anaemia due to glucose-6-phosphate dehydrogenase (G6PD) deficiency: demonstration of two new biochemical variants, G6PD Hamm and G6PD Tarsus.
Gahr M; Bornhalm D; Schröter W
Br J Haematol; 1976 Jul; 33(3):363-70. PubMed ID: 1276080
[TBL] [Abstract][Full Text] [Related]
16. Glyburide-induced acute haemolysis in a G6PD-deficient patient with NIDDM.
Meloni G; Meloni T
Br J Haematol; 1996 Jan; 92(1):159-60. PubMed ID: 8562390
[TBL] [Abstract][Full Text] [Related]
17. Acute hemolysis in a patient with a newly diagnosed glioblastoma.
Murphy AG; Grossman SA
CNS Oncol; 2016 Jul; 5(3):125-9. PubMed ID: 27230975
[TBL] [Abstract][Full Text] [Related]
18. Review and drug therapy implications of glucose-6-phosphate dehydrogenase deficiency.
Belfield KD; Tichy EM
Am J Health Syst Pharm; 2018 Feb; 75(3):97-104. PubMed ID: 29305344
[TBL] [Abstract][Full Text] [Related]
19. The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics.
Luzzatto L
Lancet; 2010 Aug; 376(9742):739-41. PubMed ID: 20599264
[No Abstract] [Full Text] [Related]
20. Dapsone-induced haemolytic anaemia, hepatitis and agranulocytosis in a leprosy patient with normal glucose-6-phosphate-dehydrogenase activity.
Ranawaka RR; Mendis S; Weerakoon HS
Lepr Rev; 2008 Dec; 79(4):436-40. PubMed ID: 19274991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
